TREA

78543928 - FLASHDOSE

Follow

Information

  • Trademark
  • 78543928
  • Serial Number
    78543928
  • Filing Date
    January 07, 2005
    19 years ago
  • Transaction Date
    July 23, 2011
    13 years ago
  • Status Date
    August 24, 2009
    15 years ago
  • Published for Opposition Date
    May 02, 2006
    18 years ago
  • Location Date
    February 05, 2009
    15 years ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    REIHNER, DAVID C
  • Attorney Docket Number
    1001.0024
    Attorney Name
    James R. Menker
    Law Office Assigned Location Code
    M20
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
FLASHDOSE
Case File Statements
  • GS0051: Pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for controlling insulin levels; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardio-vascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the immune system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculo-skeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, pain relief medication and anti-inflammatories; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances, namely, medicated skin care preparations for use in dermatology, namely, dermatitis and skin pigmentation diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for use in ophthalmology; pharmaceutical preparations and substances for the treatment of polycystic ovary syndrome; pharmaceutical preparations and substances for the treatment of infertility; pharmaceutical preparations and substances for the prevention, treatment and alleviation circulatory, neurologic, alimentary, auto-immune, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal, infectious or metabolic diseases, illnesses, disorders or conditions; metformin; diltiazem; tramadol; carvedilol; bupropion; metoprolol; citalopram; zolpidem; fluoxetine; venlafaxine; lorazepam; and sumatriptan
  • PM0000: FLASH DOSE
Case File Event Statements
  • 10/13/2010 - 14 years ago
    37 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK
  • 8/24/2009 - 15 years ago
    36 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Type: MAB6
  • 8/24/2009 - 15 years ago
    35 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 6/17/2009 - 15 years ago
    34 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK
  • 2/5/2009 - 15 years ago
    33 - EXTENSION 5 GRANTED Type: EX5G
  • 1/22/2009 - 15 years ago
    32 - EXTENSION 5 FILED Type: EXT5
  • 2/5/2009 - 15 years ago
    31 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 1/22/2009 - 15 years ago
    30 - TEAS EXTENSION RECEIVED Type: EEXT
  • 1/22/2009 - 15 years ago
    29 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 1/22/2009 - 15 years ago
    28 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 7/17/2008 - 16 years ago
    27 - EXTENSION 4 GRANTED Type: EX4G
  • 7/17/2008 - 16 years ago
    26 - EXTENSION 4 FILED Type: EXT4
  • 7/17/2008 - 16 years ago
    25 - TEAS EXTENSION RECEIVED Type: EEXT
  • 2/7/2008 - 16 years ago
    24 - EXTENSION 3 GRANTED Type: EX3G
  • 1/18/2008 - 16 years ago
    23 - EXTENSION 3 FILED Type: EXT3
  • 1/18/2008 - 16 years ago
    22 - TEAS EXTENSION RECEIVED Type: EEXT
  • 9/29/2007 - 17 years ago
    21 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 9/14/2007 - 17 years ago
    20 - EXTENSION 2 GRANTED Type: EX2G
  • 7/12/2007 - 17 years ago
    19 - EXTENSION 2 FILED Type: EXT2
  • 7/12/2007 - 17 years ago
    18 - TEAS EXTENSION RECEIVED Type: EEXT
  • 12/27/2006 - 17 years ago
    17 - EXTENSION 1 GRANTED Type: EX1G
  • 11/9/2006 - 18 years ago
    16 - EXTENSION 1 FILED Type: EXT1
  • 11/9/2006 - 18 years ago
    15 - TEAS EXTENSION RECEIVED Type: EEXT
  • 7/25/2006 - 18 years ago
    14 - NOA MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 5/2/2006 - 18 years ago
    13 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 4/12/2006 - 18 years ago
    12 - NOTICE OF PUBLICATION Type: NPUB
  • 3/14/2006 - 18 years ago
    11 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 3/10/2006 - 18 years ago
    10 - ASSIGNED TO LIE Type: ALIE
  • 3/8/2006 - 18 years ago
    9 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 3/3/2006 - 18 years ago
    8 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/9/2006 - 18 years ago
    7 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/9/2006 - 18 years ago
    6 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 8/9/2005 - 19 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 8/9/2005 - 19 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 8/9/2005 - 19 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/13/2005 - 19 years ago
    2 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 1/19/2005 - 19 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP